Biota Holdings Limited (ASX:BTA) Commences Human Rhinovirus Phase IIa Clinical Trial

  Melbourne, Australia, Aug 11, 2008 - (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced the commencement of dosing in the first Phase IIa challenge study of BTA798, an orally delivered and potent inhibitor of human rhinovirus (HRV).  

Sydney

  [ Change ]
 
Today

Min: 11°
Max: 19°
Possible shower.
Tomorrow

Min: 12°
Max: 19°
Possible shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online